ANZ
There was a lot to like in the ANZ result, not the least of which was meeting guidance, unlike NAB.
Here’s ANZ
Vs NAB. King Charles, oddly enough, has a nice cameo amidst the data below. But the point is, ANZ meets , NAB misses.
This is pretty instructive, to us.
NAB stepped back from the market, but still suffered NIM reductions over the quarter. ANZ didn’t step back from the market, and had the similar NIM impact.
Thus things worked out better for ANZ, and that was most of the impact.
ANZ is still carrying additional capital pertaining to the SUN bank acquisition. We cannot see how the regulator could reject it, given a) ANZ share would only return to the level of a few years ago b) loans are being written industry wide below the cost of capital, as a good indicator of how ferocious and indeed unhealthy the competition is c) that the US has shown us the dangers of subscale banks in context of deposit flight and too big to fail (thus ANZ taking SUN could arguably increase financial stability) and d) the regulator cannot lock SUN into a permanently sub-WACC outcome just because it wants to.
Still, the regulator doesn’t listen to us, but there you have it.
From our perspective, CBA is overvalued, NAB somewhat overvalued, ANZ quite cheap, and, deep down, the market will probably like it either way if it gets/fails to get SUN, preferring certainty over uncertainty, and WBC somewhat the wild card, out on Monday, but with the huge optionality of getting that bloated cost base down.
Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Please note that past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.